Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 19 stocks, with a combined market cap of $3,085.19 billion, total revenue of $676.65 billion and a weighted average PE ratio of 33.81.

Market Cap
3,085.19B
Revenue
676.65B
Profits
91.25B
PE Ratio
33.81
Profit Margin
13.49%
Dividend Yield
2.32%

19 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company680.04B1.74%1,695,90940.86B
2NVONovo Nordisk A/S355.54B-0.19%2,882,22540.47B
3JNJJohnson & Johnson346.99B-2.72%9,518,23287.70B
4ABBVAbbVie Inc.299.25B-1.89%3,891,14155.53B
5MRKMerck & Co., Inc.243.40B-0.02%5,725,29663.17B
6AZNAstraZeneca PLC211.12B0.40%3,237,01551.21B
7NVSNovartis AG197.01B-0.82%601,89949.94B
8PFEPfizer Inc.148.90B-1.37%16,000,29259.38B
9AMGNAmgen Inc.146.94B-0.53%989,67932.53B
10SNYSanofi128.54B-0.77%945,29454.03B
11BMYBristol-Myers Squibb Company115.46B-0.19%3,190,80747.44B
12GILDGilead Sciences, Inc.115.43B-0.37%2,111,79428.30B
13GSKGSK plc68.29B-0.50%1,657,59041.97B
14BIIBBiogen Inc.20.77B1.10%451,0739.61B
15GRFSGrifols, S.A.5.75B-0.75%268,0127.81B
16OGNOrganon & Co.4.08B-0.28%673,6796.41B
17AMRNAmarin Corporation plc227.68M-2.83%407,145241.02M
18SCLXScilex Holding Company78.70M1.54%1,114,38155.15M
19MIRAMIRA Pharmaceuticals, Inc.19.85M2.44%77,738-